(NVO) Novo Nordisk - Performance -50.6% in 12m
Compare NVO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
43.15%
#24 in Peer-Group
Rel. Strength
11.12%
#6789 in Stock-Universe
Total Return 12m
-50.58%
#148 in Peer-Group
Total Return 5y
119.24%
#16 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 19.2 |
| P/E Forward | 16.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 144.04 USD |
| 52 Week Low | 58.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 48.00 |
| Buy/Sell Signal +-5 | -1.73 |
| Support / Resistance | Levels |
|---|---|
| Support | 59.8 |
| Resistance | 85.6, 77.9, 66.0 |
12m Total Return: NVO (-50.6%) vs XLV (-9.2%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
5.06% | 156% | 390% | 61.1 | 55 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
-5.14% | -5.73% | 379% | 60.6 | 32.9 | 1.1 | 58.2% | 18.9% |
| NVS NYSE Novartis |
-4.08% | 5.28% | 60.2% | 17 | 13.2 | 1.29 | 8.70% | 9.2% |
| SOBI ST Swedish Orphan Biovitrum |
13.8% | 4.94% | 56.2% | 26.2 | 21.4 | 1.67 | 16.1% | 29% |
| NOVN SW Novartis |
0.68% | -1.02% | 39.4% | 17.3 | 13.4 | 1.33 | 9.80% | 11.2% |
| SAN PA Sanofi |
0.95% | 1.16% | 23.6% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
3.29% | -16.3% | 53.4% | 24 | 10.3 | 0.74 | -6.40% | -6.33% |
| SNY NASDAQ Sanofi |
-0.87% | 3.82% | 26% | 19.4 | 11.7 | 0.88 | -54.4% | -5.67% |
Performance Comparison: NVO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVO
| Total Return (including Dividends) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -2.50% | -7.05% | 8.99% |
| 3 Months | -15.95% | -10.73% | -3.34% |
| 12 Months | -50.58% | -9.17% | 13.71% |
| 5 Years | 119.24% | 37.57% | 114.23% |
| Trend Score (consistency of price movement) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 65.1% | -34.7% | 95.2% |
| 3 Months | -81% | -81.6% | -53.5% |
| 12 Months | -95.2% | -35.3% | 48.2% |
| 5 Years | 91.4% | 89.4% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #134 | 4.90% | -10.54% |
| 3 Month | #116 | -5.85% | -13.05% |
| 12 Month | #147 | -45.59% | -56.54% |
| 5 Years | #16 | 59.36% | 2.34% |
FAQs
Does Novo Nordisk (NVO) outperform the market?
No,
over the last 12 months NVO made -50.58%, while its related Sector, the Health Care Sector SPDR (XLV) made -9.17%.
Over the last 3 months NVO made -15.95%, while XLV made -10.73%.
Performance Comparison NVO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NVO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.4% | -11.5% | -37.5% | -64% |
| US NASDAQ 100 | QQQ | -12% | -15.9% | -40.1% | -68% |
| German DAX 40 | DAX | -6.2% | -14.5% | -59.5% | -76% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.7% | -8.8% | -37.6% | -60% |
| Hongkong Hang Seng | HSI | -7.9% | -18% | -49.7% | -63% |
| India NIFTY 50 | INDA | -6.1% | -8.3% | -39.7% | -55% |
| Brasil Bovespa | EWZ | -11.5% | -15.3% | -45.5% | -46% |
NVO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8% | -12.1% | -42.2% | -75% |
| Consumer Discretionary | XLY | -13.2% | -16.1% | -38.7% | -73% |
| Consumer Staples | XLP | -2.2% | 0.2% | -37.7% | -56% |
| Energy | XLE | -10.5% | -10.2% | -29.2% | -45% |
| Financial | XLF | -7.7% | -10.5% | -41.3% | -74% |
| Health Care | XLV | 0.2% | 4.6% | -27.7% | -41% |
| Industrial | XLI | -9.5% | -13.2% | -39.2% | -65% |
| Materials | XLB | -7.1% | -7.2% | -31.6% | -45% |
| Real Estate | XLRE | -2.7% | -4.9% | -34.4% | -61% |
| Technology | XLK | -13.1% | -19.5% | -38% | -64% |
| Utilities | XLU | -2.9% | -4.6% | -41% | -65% |
| Aerospace & Defense | XAR | -9.4% | -14.5% | -49.3% | -79% |
| Biotech | XBI | -3.4% | -2.3% | -16.6% | -35% |
| Homebuilder | XHB | -8.4% | -10% | -22.8% | -43% |
| Retail | XRT | -10.7% | -13.9% | -32.3% | -47% |
NVO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.9% | -5.61% | -34.3% | -42% |
| Natural Gas | UNG | -0.4% | -1.9% | -70.2% | -52% |
| Gold | GLD | 1% | -1.5% | -61.6% | -85% |
| Silver | SLV | -3.8% | -2.1% | -43% | -63% |
| Copper | CPER | -5.6% | -1.1% | -50.6% | -48% |
NVO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.7% | -0.4% | -34.4% | -48% |
| iShares High Yield Corp. Bond | HYG | -5.5% | -5.7% | -40.7% | -60% |